Accessed:
ChemSpider Search and share chemistrynav-icon

Toceranib

Molecular formula:C22H25FN4O2
Average mass:396.466
Monoisotopic mass:396.196154
ChemSpider ID:4486268
double-bond-stereo-icon

Double-bond stereo

plus-iconless-iconStructural identifiers
  • Names down_Arrow
plus-iconless-iconNames and synonyms
Verified

1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-

[ACD/Index Name]

356068-94-5

[RN]

5-[(Z)-(5-Fluor-2-oxo-1,2-dihydro-3H-indol-3-yliden)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrol-3-carboxamid

[German]

[ACD/IUPAC Name]

5-[(Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide

[ACD/IUPAC Name]

5-[(Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidène)méthyl]-2,4-diméthyl-N-[2-(1-pyrrolidinyl)éthyl]-1H-pyrrole-3-carboxamide

[French]

[ACD/IUPAC Name]

5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide

59L7Y0530C

[UNII]

Toceranib

[INN] [USAN]

tocéranib

[French]

[INN]

toceranib

[Spanish]

[INN]

toceranibum

[Latin]

[INN]
Unverified

(Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrole-3-carboxamide

(Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide

(Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide;SU-11654

1795134-78-9

[RN]

356068-94-5 (free base)

5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide

5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-(pyrrolidin-1-yl)ethyl)amide

5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide

5-[(Z)-(5-fluoro-2-keto-indolin-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide

5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide

5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide

5-[(Z)-(5-fluoro-2-oxo-3-indolinylidene)methyl]-2,4-dimethyl-N-(2-1-pyrrolidinylethyl)-1H-pyrrole-3-carboxamide

5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide

EGFR_HUMAN

Epidermal growth factor receptor

FGFR1_HUMAN

Fibroblast growth factor receptor 1

Methyl 2-oxoacetate

MFCD16038046

[MDL number]

Palladia

[Trade name]

PGFRB_HUMAN

tocéranib

toceranib discontinued pfizer patent issues

Toceranib free base

Toceranib(SU 11654; PHA 291639)

Toceranib-d8

toceranibum

VGFR2_HUMAN

тоцераниб

[Russian]

توسيرانيب

[Arabic]

托西尼布

[Chinese]
plus-iconless-iconDatabase IDs